CHLORDIAZEPOXIDE HYDROCHLORIDE - Generic Drug Details
✉ Email this page to a colleague
What are the generic sources for chlordiazepoxide hydrochloride and what is the scope of patent protection?
Chlordiazepoxide hydrochloride
is the generic ingredient in seven branded drugs marketed by Abbott, Rachelle, Ascot, Barr, Chartwell Rx, Ferrante, Halsey, Impax Labs, Ivax Sub Teva Pharms, Lederle, Mast Mm, Mylan, Parke Davis, Pioneer Pharms, Purepac Pharm, Roxane, Superpharm, Teva, Upsher Smith Labs, Usl Pharma, Vangard, Watson Labs, West Ward, Bausch, Valeant Pharm Intl, Alra, Alembic, Alkem Labs Ltd, Amneal, Aurobindo Pharma Ltd, Corepharma, Dr Reddys, Micro Labs, Misemer, Nuvo Pharms Inc, Teva Pharms Usa, and Torrent, and is included in ninety-two NDAs. Additional information is available in the individual branded drug profile pages.There are two drug master file entries for chlordiazepoxide hydrochloride. Fourteen suppliers are listed for this compound.
Summary for CHLORDIAZEPOXIDE HYDROCHLORIDE
US Patents: | 0 |
Tradenames: | 7 |
Applicants: | 37 |
NDAs: | 92 |
Drug Master File Entries: | 2 |
Finished Product Suppliers / Packagers: | 14 |
Raw Ingredient (Bulk) Api Vendors: | 1 |
Clinical Trials: | 8 |
Formulation / Manufacturing: | see details |
What excipients (inactive ingredients) are in CHLORDIAZEPOXIDE HYDROCHLORIDE? | CHLORDIAZEPOXIDE HYDROCHLORIDE excipients list |
DailyMed Link: | CHLORDIAZEPOXIDE HYDROCHLORIDE at DailyMed |
Recent Clinical Trials for CHLORDIAZEPOXIDE HYDROCHLORIDE
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
Mayo Clinic | Phase 4 |
Oregon Health and Science University | Phase 2 |
Taipei City Hospital | Phase 2/Phase 3 |
Pharmacology for CHLORDIAZEPOXIDE HYDROCHLORIDE
Drug Class | Benzodiazepine |
Anatomical Therapeutic Chemical (ATC) Classes for CHLORDIAZEPOXIDE HYDROCHLORIDE
US Patents and Regulatory Information for CHLORDIAZEPOXIDE HYDROCHLORIDE
Expired US Patents for CHLORDIAZEPOXIDE HYDROCHLORIDE
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Valeant Pharm Intl | LIBRIUM | chlordiazepoxide hydrochloride | CAPSULE;ORAL | 012249-002 | Approved Prior to Jan 1, 1982 | ⤷ Sign Up | ⤷ Sign Up |
Valeant Pharm Intl | LIBRIUM | chlordiazepoxide hydrochloride | CAPSULE;ORAL | 012249-003 | Approved Prior to Jan 1, 1982 | ⤷ Sign Up | ⤷ Sign Up |
Valeant Pharm Intl | LIBRIUM | chlordiazepoxide hydrochloride | CAPSULE;ORAL | 012249-001 | Approved Prior to Jan 1, 1982 | ⤷ Sign Up | ⤷ Sign Up |
Bausch | LIBRIUM | chlordiazepoxide hydrochloride | INJECTABLE;INJECTION | 012301-001 | Approved Prior to Jan 1, 1982 | ⤷ Sign Up | ⤷ Sign Up |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.